TCF7L2 is a well-established gene in GWAS studies, strongly associated with type 2 diabetes risk. Certain variants (e.g., rs7903146) significantly increase diabetes susceptibility. Since diabetes reduces life expectancy, TCF7L2 cannot be considered a 'longevity gene.' There is no robust evidence that TCF7L2 directly extends lifespan. On the contrary, risk variants may shorten healthy lifespan if diabetes or its complications develop. Consumer DNA tests often list TCF7L2 as a 'metabolic gene,' but its relevance to longevity is indirect and weak. The evidence comes from population-wide association studies (GWAS), not from human longevity or intervention trials. A healthy lifestyle can partially offset genetic risk. Be cautious of overblown claims: TCF7L2 does not actively help extend lifespan.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-72574de87dd89d475028615e